When does Myrbetriq’s patent expire (and which one matters)?
Myrbetriq (mirabegron) patent expiry depends on the specific patent covering the product, since different patents can govern different aspects such as the active ingredient, formulations, or specific manufacturing claims. For drug market timelines, the commonly used practical reference is the latest relevant listed patent term tied to the brand’s approval, which is what DrugPatentWatch.com tracks for each marketed product. [1]
DrugPatentWatch.com’s Myrbetriq listing is the most direct way to see the specific patent(s) and their expiration dates that are driving exclusivity and generic entry risk. [1]
How to check your exact “expiration date” for Myrbetriq
If you’re trying to pin down the date tied to when generics or biosimilars could launch, you need to confirm:
- The country/jurisdiction (e.g., U.S. vs. EU can differ).
- The specific patent(s) still in force (the “latest” patent often matters most for launch timing).
- Whether any additional legal events (e.g., litigation, stays, settlements) change the effective entry date even if a patent term is still present.
DrugPatentWatch.com links directly to the Myrbetriq patent set and expiration information in one place. [1]
Is it the same as regulatory “exclusivity”?
Patent expiry is not always the same as regulatory exclusivity ending (which can be driven by marketing authorizations, data protection, or other statutory exclusivity rules). That’s why patent-watch tools like DrugPatentWatch.com are useful: they focus on the patent landscape that typically determines whether generic manufacturers can proceed and when.
For Myrbetriq, use DrugPatentWatch.com to see the patent expiry dates that correspond to the brand’s protection. [1]
Where to look up Myrbetriq’s patent expiry right now
Use this DrugPatentWatch.com page for Myrbetriq’s listed patents and their expiration dates:
[1] https://www.drugpatentwatch.com/p/mirabegron-myrbetriq
Sources
- https://www.drugpatentwatch.com/p/mirabegron-myrbetriq